[A case of metastatic cancer of unknown primary origin that progressed rapidly after complete remission via second-line chemotherapy].
Leptomeningeal metastasis occurs in approximately 5% of patients with metastatic solid carcinomas, and it is often diagnosed in patients with breast cancer, lung cancer, malignant melanoma, and digestive cancer. Herein, we report a case of a metastatic cancer of unknown primary origin. The leptomeningeal metastasis progressed quite rapidly, and the patient died despite achieving complete remission via second-line chemotherapy.
Dept. of Respiratory Medicine, Saiseikai Senri Hospital.
Yuki
Y
Akazawa
Yoshihiko
Y
Taniguchi
Hisanori
H
Mima
Hiroshi
H
Tagawa
Toshie
T
Niki
Toshiki
T
Funakoshi
D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D000077143:Docetaxel; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy*; D012074:Remission Induction; D043823:Taxoids / Q000008:administration & dosage
D061067:Antibodies, Monoclonal, Humanized; D043823:Taxoids; D000077143:Docetaxel; D000068258:Bevacizumab